SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Nome Químico: (2Z,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid Sodium salt (as per EP)
Sinônimo: 9,13-di-cis-retinoic acid ; 9-cis,13-cis-Retinoic Acid
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: CC1(C)C(/C=C/C(C)=C\C=C\C(C)=C/C(O)=O)=C(C)CCC1.[Na]
Tretinoin EP Impurity B Sodium salt is chemically (2Z,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid Sodium salt (as per EP). It is also known as 9,13-di-cis-retinoic acid ; 9-cis,13-cis-Retinoic Acid. Tretinoin EP Impurity B Sodium salt is supplied with detailed characterization data compliant with regulatory guideline. Tretinoin EP Impurity B Sodium salt can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tretinoin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Development and validation of analytical spectrophotometric and RP-HPLC methods for the simultaneous estimation of hydroquinone, hydrocortisone and tretinoin ternary mixture in topical formulation
By Al Jamal, Marwa K.; Gazy, Azza A.
From International Journal of Pharmacy and Pharmaceutical Sciences (2019), 11(11), 10-16
Stability indicating simultaneous validation of azelaic acid, minoxidil and tretinoin with forced degradation behavior study by RP-HPLC in pharmaceutical dosage form
By Sharma, Akhilesh; Mishra, Anurag; Sharma, Sanjay
From European Journal of Biomedical and Pharmaceutical Sciences (2016), 3(11), 272-281